Literature DB >> 32062769

Risk factors of ultrasound-detected tophi in patients with gout.

Beilei Lu1, Qing Lu1, Beijian Huang2,3, Cuixian Li1,4, Fengyang Zheng1,4, Peilei Wang1.   

Abstract

INTRODUCTION: Tophus is a characteristic manifestation of advanced gout, the clinical significance of which is often underestimated. This study aimed to compare the difference of clinical and ultrasound features between gout patients with and without ultrasound-detected tophus and identify risk factors associated with the presence of ultrasonographic tophus in gout patients.
MATERIALS AND METHODS: A total of 85 gout patients were divided into tophaceous (n = 54) and non-tophaceous group (n = 31) according to the presence of ultrasound-detected tophus. All patients underwent ultrasound examination of the bilateral knee, ankle, and first metatarsophalangeal joint (MTP1). Clinical information and ultrasound findings were compared between the groups. A multivariate logistic regression analysis to determine possible risk factors is associated with the number of ultrasound-detected tophaceous joints.
RESULTS: Older age, longer gout duration, higher gout flare frequency, lower estimated glomerular filtration rate (eGFR), and higher prevalence of hypertension, hyperlipidemia, and ultrasound manifestations including double contour sign (DCS) and erosion were observed in tophaceous patients from the univariate analysis. Multivariable logistic regression analysis showed that eGFR and disease duration were independently associated with the number of tophaceous joints. Lower eGFR and longer course duration were associated with a higher risk of tophi (B = -0.020, 0.141; P = 0.009, 0.010, respectively).
CONCLUSIONS: The main factors that may influence the formation of tophi are disease duration and eGFR.Key Points• Lower eGFR and longer course duration are independent risk factors of tophi formation in gout patients.• The incidence of ultrasound manifestations including double contour sign (DCS) and erosion in patients with tophi were higher than those without tophi.

Entities:  

Keywords:  Duration; EGFR; Gout; Tophi; Ultrasound

Mesh:

Substances:

Year:  2020        PMID: 32062769     DOI: 10.1007/s10067-020-04947-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study.

Authors:  Jiaojiao Jing; Jan T Kielstein; Ulla T Schultheiss; Thomas Sitter; Stephanie I Titze; Elke S Schaeffner; Mara McAdams-DeMarco; Florian Kronenberg; Kai-Uwe Eckardt; Anna Köttgen
Journal:  Nephrol Dial Transplant       Date:  2014-11-13       Impact factor: 5.992

2.  Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.

Authors:  Yanyan Zhu; Bhavik J Pandya; Hyon K Choi
Journal:  Am J Med       Date:  2012-05-23       Impact factor: 4.965

3.  Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study.

Authors:  Lidan Ma; Ruixia Sun; Zhaotong Jia; Yaowu Zou; Ying Xin; Xiaoyu Cheng; Tian Liu; Lingling Cui; Zhen Liu; Xinjiang Wu; Changgui Li
Journal:  Clin Rheumatol       Date:  2018-01-22       Impact factor: 2.980

Review 4.  Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide.

Authors:  Nicola Dalbeth; Cameron Schauer; Patricia Macdonald; Fernando Perez-Ruiz; H Ralph Schumacher; Steve Hamburger; Hyon K Choi; Fiona M McQueen; Anthony Doyle; William J Taylor
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

5.  Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.

Authors:  Fernando Perez-Ruiz; Lorea Martínez-Indart; Loreto Carmona; Ana Maria Herrero-Beites; Jose Ignacio Pijoan; Eswar Krishnan
Journal:  Ann Rheum Dis       Date:  2013-01-12       Impact factor: 19.103

Review 6.  Chronic gout in the elderly.

Authors:  Francesco Bolzetta; Nicola Veronese; Enzo Manzato; Giuseppe Sergi
Journal:  Aging Clin Exp Res       Date:  2013-04-09       Impact factor: 3.636

7.  Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout.

Authors:  Nicola Dalbeth; Meaghan E House; Anne Horne; William J Taylor
Journal:  BMC Musculoskelet Disord       Date:  2013-12-21       Impact factor: 2.362

8.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Tuhina Neogi; Tim L Th A Jansen; Nicola Dalbeth; Jaap Fransen; H Ralph Schumacher; Dianne Berendsen; Melanie Brown; Hyon Choi; N Lawrence Edwards; Hein J E M Janssens; Frédéric Lioté; Raymond P Naden; George Nuki; Alexis Ogdie; Fernando Perez-Ruiz; Kenneth Saag; Jasvinder A Singh; John S Sundy; Anne-Kathrin Tausche; Janitzia Vaquez-Mellado; Steven A Yarows; William J Taylor
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

Review 9.  What makes gouty inflammation so variable?

Authors:  Robert Terkeltaub
Journal:  BMC Med       Date:  2017-08-18       Impact factor: 8.775

Review 10.  2016 updated EULAR evidence-based recommendations for the management of gout.

Authors:  P Richette; M Doherty; E Pascual; V Barskova; F Becce; J Castañeda-Sanabria; M Coyfish; S Guillo; T L Jansen; H Janssens; F Lioté; C Mallen; G Nuki; F Perez-Ruiz; J Pimentao; L Punzi; T Pywell; A So; A K Tausche; T Uhlig; J Zavada; W Zhang; F Tubach; T Bardin
Journal:  Ann Rheum Dis       Date:  2016-07-25       Impact factor: 19.103

View more
  4 in total

Review 1.  Critical appraisal of serum urate targets in the management of gout.

Authors:  Lisa K Stamp; Nicola Dalbeth
Journal:  Nat Rev Rheumatol       Date:  2022-08-16       Impact factor: 32.286

2.  Simple metabolic markers associated with tophaceous gout.

Authors:  Wei Liu; Hui Song; Siliang Man; Hongchao Li; Siming Gao
Journal:  Clin Rheumatol       Date:  2021-07-15       Impact factor: 2.980

3.  Cynarin suppresses gouty arthritis induced by monosodium urate crystals.

Authors:  Changgui Wu; Shaohua Chen; Yang Liu; Bo Kong; Wei Yan; Tao Jiang; Hao Tian; Zhaoyi Liu; Qi Shi; Yongjun Wang; Qianqian Liang; Xiaobing Xi; Hao Xu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Quantitative assessment of crystal dissolution in gout during urate-lowering therapy with computer-aided MicroPure imaging: a cohort study.

Authors:  Qiao Wang; Hui Bao; Le-Hang Guo; Feng-Shan Jin; Xiao-Long Li; Hao-Hao Yin; Wen-Wen Yue; An-Qi Zhu; Li-Fan Wang; Li-Ping Sun; Hui-Xiong Xu
Journal:  Ann Transl Med       Date:  2021-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.